We are live on
!
Find out more
VMV
Venrock Management VI Portfolio holdings
AUM
$47.6M
1-Year Est. Return
45.26%
This Fund
S&P 500
This Quarter
Est. Return
+35.66%
1 Year Est. Return
-45.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$118M
AUM Growth
–
Cap. Flow
+$91.7M
Cap. Flow
% of AUM
77.76%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$91.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
10x Genomics
TXG
$5.88B
| $118M | 100% |
+2,106,757
| New | +$91.7M |
|
Similar funds
BHH
BHCM
MG
LAMC
CLCM
MAM
BCM
AS
Venrock Management VI's Q4 2023 Portfolio in Review
Q4 2023 is the first quarter with a 13F filing on record for Venrock Management VI, which disclosed 1 position worth $118M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is 10x Genomics: 2,106,757 shares worth $118M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Venrock Management VI's largest Q4 2023 buy was 10x Genomics: 2,106,757 shares worth $118M.
- Venrock Management VI's ten largest holdings make up 100% of its $118M portfolio in Q4 2023.
- Venrock Management VI disclosed 1 position in Q4 2023, its first 13F filing on record.
Based on Venrock Management VI's 13F filing for Q4 2023, filed 14 Feb 2024.